RENN Asia Wellness (RENN), a home-grown brand focusing on Nutritional and Functional Medicine (NFM), is pioneering Malaysia-China cooperation in this field with the opening of a centre in Guangzhou, China.
In collaboration with Jian Shi Tang (JST) of Guangzhou and adopting its Malaysian-developed NFM clinical framework, RENN will operate a first-of-its-kind wellness centre at the prestigious Leatop Plaza in Tianhe District of Guangzhou.
This collaboration places Malaysia among the first in the region to export a full chronic-disease management model to China, starting with diabetes care.
China is grappling with one of the world’s largest diabetes epidemics, estimated at more than 140 million adults. Rising complications and healthcare expenditures have accelerated the search for preventive and functional medicine solutions capable of reducing long-term disease progression.
Despite strong national efforts, persistent gaps remain in preventive and functional care models, particularly those that integrate nutrition, root-cause investigation, lifestyle medicine, personalised diagnostics, and long-term monitoring. The introduction of a Malaysian-developed NFM framework is seen as a strategic complement to China’s evolving healthcare reforms.
The Malaysian-led NFM initiative offers a structured, root-cause focused alternative. Rather than merely managing symptoms, NFM emphasises personalised assessment, lifestyle and nutrition intervention, metabolic optimisation and preventive care. By doing so, it aims to stabilise or even reverse elements of metabolic dysfunction, a critically needed tool in China’s fight against chronic disease.
RENN Asia will supply not only the NFM protocols and programme design but also experienced Malaysian practitioners as advisers for the initial launch phase. This approach ensures that the first centre accurately reflects the rigorous standards and holistic philosophy developed in Malaysia through years of clinical experience.
“Bringing a Malaysian-refined NFM framework into China shows that we can be a provider of practical healthcare solutions to other nations. Our role is not only to export knowledge, but to support JST in building a system that can sustainably transform community health outcomes in Guangzhou and eventually across China,” said Jonathan Chew, Founder and CEO of RENN.
“For JST, we see tremendous potential in RENN Asia’s NFM framework. Its emphasis on personalised assessment and root-cause intervention aligns with the future direction of healthcare in China,” said JST lead medical practitioner Dr Dai Qi Ming.
Both organisations plan to scale the partnership to other chronic conditions once the diabetes programme demonstrates stable outcomes. Future expansion areas include cardiovascular disease, liver and metabolic disorders, hormonal imbalances, and allergy-related conditions — all of which contribute significantly to China’s rising chronic disease burden.
The joint initiative aims to generate long-term impact by reducing avoidable complications, lowering treatment costs, and improving clients’ independence and quality of life. Through this collaboration, Malaysia’s contribution extends beyond clinical expertise to knowledge export, professional capacity building, and regional health innovation.
